Takeda | 4502 - Cash And Equivalent


Takeda reported JPY654.94B in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Astellas Pharma JPY 188.37B 8.51B Mar/2025
Chugai Pharma JPY 426.6B 29.83B Dec/2025
Daiichi Sankyo JPY 542.16B 97.68B Sep/2025
Eisai JPY 301.65B 16.27B Sep/2025
Kyowa Hakko Kirin JPY 218.77B 15.83B Dec/2025
M3 JPY 133.85B 1.09B Sep/2025
Otsuka Holdings JPY 534.64B 123.53B Dec/2025
Shionogi JPY 233.86B 20.96B Sep/2025
Sumitomo Dainippon JPY 38.49B 15.37B Sep/2025
Takeda JPY 654.94B 26.55B Dec/2025
Terumo JPY 217.16B 12.86B Sep/2025